#nasdaq:fprx

[marketexclusive]

Bristol-Myers Squibb Co (NYSE:BMY) To Revamp Its Research And Development

Bristol-Myers Squibb Co (NYSE:BMY) To Revamp Its Research And Development

Bristol-Myers Squibb Co (NYSE:BMY) is seeking to reshape its research and development footprint across the U.S. With that, the company says it will be shutting down a host of it centers while integrating others. The integration, which is meant to foster greater speed and collaboration, will involve biologics development with clinical manufacturing at key sites. The R&D hub of innovation in Jew…

View On WordPress

[marketexclusive]

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Files An 8-K Entry into a Material Definitive Agreement

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Files An 8-K Entry into a Material Definitive Agreement

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Files An 8-K Entry into a Material Definitive Agreement Item1.01 Entry into a Definitive Material Agreement On December12, 2016, Five Prime Therapeutics, Inc. (FivePrime) and HCP Oyster Point III LLC (Landlord) entered into the Lease (the Lease), effective December12, 2016 (the Effective Date), for FivePrimes lease of 115,466 square feet of office and…

View On WordPress